Pediatric Clinical Trials
Pediatric Clinical Trials: Considerations for Enrollment and Retention
Susan McCune, M.D.; Anusha Streubel, M.D.; Elizabeth Donahue
PAO-02-24-CL-04Mar 01, 2024
Neurodegenerative Disease Clinical Trials
Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants
John Hamlet; Christine Martino, MPM; Sabine Krofczik-Wilhelm, Ph.D.; Alberto Lledó, M.D., Ph.D.
PPD clinical research business of Thermo Fisher Scientific
PAO-09-022-CL-09Sep 27, 2022
Column: Clinical Trials
How Artificial Intelligence May Drive the Future of Clinical Trials
James Grote
Nice Insight
PAO-03-022-NI-01Mar 23, 2022
Business Leadership
Former Surgeon General Jerome Adams Announced as Chairman of the Board of Total Diversity Clinical Trial Management
TOTAL Diversity Clinical Trial Management
PR-M03-22-04Mar 08, 2022
Patient Enrollment
Inhibrx Announces Enrollment of First Patient in Phase 1 Study of INBRX-101, a Modified Recombinant Human AAT-Fc Fusion Protein
Inhibrx, Inc.
PR-M09-19-NI-023Sep 10, 2019
Clinical Trials
uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B
uniQure
PR-M09-19-NI-013Sep 06, 2019